Cargando…
PDX1-engineered embryonic stem cell-derived insulin producing cells regulate hyperglycemia in diabetic mice
BACKGROUND: Type 1 diabetes can be treated by the transplantation of cadaveric whole pancreata or isolated pancreatic islets. However, this form of treatment is hampered by the chronic shortage of cadaveric donors. Embryonic stem (ES) cell-derived insulin producing cells (IPCs) offer a potentially n...
Autores principales: | Raikwar, Sudhanshu P, Zavazava, Nicholas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3560994/ https://www.ncbi.nlm.nih.gov/pubmed/23369186 http://dx.doi.org/10.1186/2047-1440-1-19 |
Ejemplares similares
-
Human iPS Cell-Derived Insulin Producing Cells Form Vascularized Organoids under the Kidney Capsules of Diabetic Mice
por: Raikwar, Sudhanshu P., et al.
Publicado: (2015) -
Insulin-producing cells from embryonic stem cells rescues hyperglycemia via intra-spleen migration
por: Ren, Meng, et al.
Publicado: (2014) -
Pancreatic Insulin-Producing Cells Differentiated from Human Embryonic Stem Cells Correct Hyperglycemia in SCID/NOD Mice, an Animal Model of Diabetes
por: Hua, Xiu-feng, et al.
Publicado: (2014) -
Transcriptional Regulation of Human NANOG by Alternate Promoters in Embryonic Stem Cells
por: Das, Satyabrata, et al.
Publicado: (2012) -
The combined effect of Pdx1 overexpression and Shh manipulation on the function of insulin‐producing cells derived from adipose‐tissue stem cells
por: Hashemi Tabar, Mahmoud, et al.
Publicado: (2018)